Technical analysis of Biohaven Ltd. (BHVN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that i...
Price
| Price | $12.02 |
| Market Cap | $1.8B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| Price / Book | 141.63 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 24.30 |
| Current Ratio | 4.73 |
Related companies: ABCL · CLDX · IMCR · IMNM · NTLA · PHVS · SION
Explore sector: Healthcare · Biotechnology
More sections of BHVN: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks